key: cord-0252304-jx93b54b
authors: Gargouri, Rahma; Moussa, Nadia; Henteti, Yosser; Saidani, Amal; Kallel, Nesrin; Kacem, Jihen Hadj; Kotti, Amina; Mnif, Zeineb; Kamoun, Samy
title: An isolated spontaneous pneumomedistinum as a rare complication of COVID 19
date: 2021-07-01
journal: Tunis Med
DOI: nan
sha: 1fb0b5026499c177e148d721aae59462e0684745
doc_id: 252304
cord_uid: jx93b54b

The Coronavirus Disease 2019 (COVID-19) pandemic has displayed heterogeneity in disease manifestations and complications. This case report illustrates a rare issue : the spontaneous pneumomediastinum. A 73-year-old male presented with chills, and respiratory symptoms. A reverse transcriptase polymerase chain reaction (RT-PCR) test- confirmed COVID19. At admission, the patient was in severe respiratory distress. C reactive protein was 54 mg/l (normal: 0-5 mg/l), , troponin were negative, brain natriuretic peptid 55 pg/ml (normal range <100 pg/ml) and D-dimer 700 mcg/l (normal: 0-500 mcg/l). Arterial blood gases showed pH 7.49 (normal: 7.35-7.45), PCO2 33,8 mmHg (normal: 34-46 mmHg) and PO2 56 mmHg (normal: 80-97 mmHg) with 16 liter per minute of oxygen. Computed tomography of the chest (CT chest) showed diffuse groundglass opacities (60-70%) without pulmonary embolism. Diagnosis of acute respiratory distress syndrome (ARDS) was made. Low flow oxygen was provided (Oxygen saturation target ≥ 94%), intermediate dose of low molecular weight heparin and 8mg of dexamethason were administarted daily. On day 10, worsening hemodynamics and blood oxygen levels was noted. CT chest showed moderate bilateral pneumomediastinum, without pneumothorax, persistent groundglass opacities (75%) with early fibrosis elements. The patient recovered with no pulmonary sequelae. This case report encourages health workers to get used with infrequent clinical and radiological manifestations of COVID-19 that is still surprising the world.

The Coronavirus Disease 2019 (COVID-19) pandemic has displayed heterogeneity in disease manifestations and complications. This case report illustrates a rare issue : the spontaneous pneumomediastinum. A 73-year-old male presented with chills, and respiratory symptoms. A reverse transcriptase polymerase chain reaction (RT-PCR) test-confirmed COVID19. At admission, the patient was in severe respiratory distress. C reactive protein was 54 mg/l (normal: 0-5 mg/l), , troponin were negative, brain natriuretic peptid 55 pg/ml (normal range <100 pg/ml) and D-dimer 700 mcg/l (normal: 0-500 mcg/l). Arterial blood gases showed pH 7.49 (normal: 7.35-7.45), PCO2 33,8 mmHg (normal: 34-46 mmHg) and PO2 56 mmHg (normal: 80-97 mmHg) with 16 liter per minute of oxygen. Computed tomography of the chest (CT chest) showed diffuse groundglass opacities (60-70%) without pulmonary embolism. Diagnosis of acute respiratory distress syndrome (ARDS) was made. Low flow oxygen was provided (Oxygen saturation target ≥ 94%), intermediate dose of low molecular weight heparin and 8mg of dexamethason were administarted daily. On day 10, worsening hemodynamics and blood oxygen levels was noted. CT chest showed moderate bilateral pneumomediastinum, without pneumothorax, persistent groundglass opacities (75%) with early fibrosis elements. The patient recovered with no pulmonary sequelae. This case report encourages health workers to get used with infrequent clinical and radiological manifestations of COVID-19 that is still surprising the world. Key words : COVID-19, spontaneous pneumomediastinum, acute respiratory distress, COVID-19 complications

The Coronavirus Disease 2019 (COVID-19) pandemic has displayed heterogeneity in disease manifestations and complications; cardiac, renal, neurological complications and coagulopathy are reported. This case report illustrates infrequently reported complication of progressive COVID 19, spontaneous pneumomediastinum.

A 73-year-old male with a past medical history of hypertension presented to the emergency room with chills, non productive cough, shortness of breath, and moderate chest pain. He was admitted in our departement after a reverse transcriptase polymerase chain reaction (RT-PCR) test-confirmed COVID19. On initial evaluation, the patient was afebrile and hemodynamically stable. He was in severe respiratory distress with tachypnea and with a pulse oximetry reading of 76% breathing room air and of 91% on 15L/min supplemental oxygen by non-rebreather mask.

Laboratory investigation showed white blood cells of 12.3x1000/mm3 (normal: 3.4-9.4x1000/ mm3) [differential: 82%(normal: 47-67%) neutrophils and 12% ( normal: 25-45%) lymphocytes], C reactive protein 54 mg/l (normal: 0-5 mg/l), blood sugar 14 mmol/l, troponin were negative, brain natriuretic peptid 55 pg/ml (normal range <100 pg/ml) and D-dimer 700 mcg/l (normal: 0-500 mcg/l). Arterial blood gases showed pH 7.49 (normal: 7.35-7.45), PCO2 33,8 mmHg (normal: 34-46 mmHg) and PO2 56 mmHg (normal: 80-97 mmHg) with 16 liter per minute of oxygen. The patient's remaining blood work results including kedney and liver fonctions, the remainder of the comprehensive metabolic panel, lactate, and creatine phosphokinase were all within normal limits. Transthoracic echography did not show signs of congestion or pulmonary embolism. Computed tomography of the chest (CT chest) showed diffuse groundglass opacities (60-70%) without pulmonary embolism too. Diagnosis of acute respiratory distress syndrome (ARDS) was made. Neither invasive nor positive-pressure ventilation was necessary. Low flow oxygen was provided (Oxygen saturation target ≥ 94%), intermediate dose of low molecular weight heparin and 8mg of dexamethason were administarted daily. On day 10, worsening hemodynamics and blood oxygen levels was noted. Ventral decubitus was not effective. CT chest showed moderate bilateral pneumomediastinum, without pneumothorax, persistent groundglass opacities (75%) with early fibrosis elements (figure 1). The evolution was marked by and emprovement and we descreased the oxygen flow gradually. 

COVID-19 causes pulmonary involvement ranging from atypical pneumonia to ARDS. Few cases of COVID-19associated pneumomediastinum are reported in the literature. Barotrauma from mechanical ventilation accounts for one third cases of pneumomediastinum [1] . Whereas, this case report highlights one infrequently noted complication of COVID-19 wich is spontaneous pneumomediastinum [2-3]. « Macklin effect » that causes this complication includes blunt traumatic alveolar ruptures, air dissection along bronchovascular sheaths, and spreading of this blunt pulmonary interstitial emphysema into the mediastinum [4-5-6] . The patient presented in this case probably had increased intrathoracic pressure caused by coughing because of heavy inflammatory burden. Alveolar walls were fragile due to diffuse alveolar cell damage from SARS-CoV-2, that infects alveolar type II cells [7] . All of this, may promote alveolar cystic rupture Different mechanisms, such as anatomic abnormalities (ie, emphysematous bullae), genetical predisposition (ie, history of spontaneous pneumothorax), inflammatorymediated lung stiffness (ie, COVID19-related pulmonary fibrosis) may play a role too. A spontaneous pneumothorax and sub cutaneous emphysema are possible complications of spontaneous pneumomediastinum with released alveolar air being trapped in the pleural cavity, but luckily, it was not the case in this report [4] [5] [6] [7] .

Moreover, the absence of pneumothorax and the moderate pneumomediastinum, which was particularly evident in this patient may be explained by the pneumonia-related lung stiffness that led to greater air expansion in the more compliant mediastinum [8] COVID-19 causes pulmonary involvements with various prognosis, that depend on comorbidities, late or inadequat treatment, extension of the pulmonary damages and complications occurence. Pneumomediastinum may reduce chances of survive. The issues are worse if it is related to barotrauma. Fortunately it was not the case of our patient.

The COVID-19 outbreak has resulted in a global health emergency. It is compulsory for health workers to get used with both typical symptoms and imaging results for COVID-19 as well as less commonly reported complications of progressive COVID-19, such as spontaneous pneumomediastinum documented in this case.

Pneumomediastinum in a critically ill coronavirus disease 2019 (covid-19) patient

Chest imaging in patients hospitalized with COVID-19 infection -a case series

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study

Spontaneous pneumomediastinum after electronic cigarette use

Spontaneous pneumomediastinum and Macklin effect: overview and appearance on computed tomography

Malignant interstitial emphysema of the lungs and mediastinum as an important occult complication in many respiratory diseases and other conditions: an interpretation of the clinical literature in the light of laboratory experiment

Pathogenesis of COVID-19 from a cell biologic perspective

MD* Massive Spontaneous Subcutaneous Emphysema and Pneumomediastinum as Rare Complications

Journal of cardiothoracic and vascular anesthesia